Gene · 8644
Papers2,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,828
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Antiepileptic Drug Oxcarbazepine Inhibits the Growth of Patient-Derived Isocitrate Dehydrogenase Mutant Glioma Stem-like Cells. | Cells | 2023 | 37190109 | PubTator, text mining | PubMed |
| Strategies to Re-Sensitize Castration-Resistant Prostate Cancer to Antiandrogen Therapy. | Biomedicines | 2023 | 37189723 | PubTator, text mining | PubMed |
| Mechanistic insights into the development of severe fetal growth restriction. | Clin Sci (Lond) | 2023 | 37186255 | PubTator, text mining | PubMed |
| Arachidonic Acid Pathways and Male Fertility: A Systematic Review. | Int J Mol Sci | 2023 | 37175913 | PubTator, text mining | PubMed |
In Silico and In Vitro Assessment of Carbonyl Reductase 1 Inhibition Using ASP9521-A Potent Aldo-Keto Reductase 1C3 Inhibitor with the Potential to Support Anticancer Therapy Using Anthracycline Antibiotics. | Molecules | 2023 | 37175180 | PubTator, text mining | PubMed |
| Genome-Wide Screening Identifies Gene AKR1C1 Critical for Resistance to Pirarubicin in Bladder Cancer. | Cancers (Basel) | 2023 | 37173953 | PubTator, text mining | PubMed |
| Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, and clinical activity of OBI-3424 in patients with advanced or metastatic solid tumors. | Br J Cancer | 2023 | 37173365 | PubTator, text mining | PubMed |
| Androgen signalling in the ovaries and endometrium. | Mol Hum Reprod | 2023 | 37171897 | PubTator, text mining | PubMed |
| A novel AKR1C3 specific prodrug AST-3424 and its combination therapy in hepatocellular carcinoma. | J Pharmacol Sci | 2023 | 37169481 | PubTator, text mining | PubMed |
| Whole-exome sequencing study of hypospadias. | iScience | 2023 | 37168556 | PubTator, text mining | PubMed |
| A genomic enhancer signature associates with hepatocellular carcinoma prognosis. | JHEP Rep | 2023 | 37168287 | PubTator, text mining | PubMed |
| Identification and validation of metabolism-related genes signature and immune infiltration landscape of rheumatoid arthritis based on machine learning. | Aging (Albany NY) | 2023 | 37166429 | PubTator, text mining | PubMed |
| The KEAP1-NRF2 pathway: Targets for therapy and role in cancer. | Redox Biol | 2023 | 37146513 | PubTator, text mining | PubMed |
| Pathologic Mechanisms of the Newcastle Disease Virus. | Viruses | 2023 | 37112843 | PubTator, text mining | PubMed |
| Description of Chemical Synthesis, Nuclear Magnetic Resonance Characterization and Biological Activity of Estrane-Based Inhibitors/Activators of Steroidogenesis. | Molecules | 2023 | 37110733 | PubTator, text mining | PubMed |
| Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical Need. | Int J Mol Sci | 2023 | 37108089 | PubTator, text mining | PubMed |
| The utility of 3D models to study cholesterol in cancer: Insights and future perspectives. | Front Oncol | 2023 | 37077827 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing depicts metabolic changes in children with aplastic anemia. | Front Oncol | 2023 | 37064094 | PubTator, text mining | PubMed |
| Immune cells and their related genes provide a new perspective on the common pathogenesis of ankylosing spondylitis and inflammatory bowel diseases. | Front Immunol | 2023 | 37063924 | PubTator, text mining | PubMed |
| Ferroptosis landscape in prostate cancer from molecular and metabolic perspective. | Cell Death Discov | 2023 | 37061523 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8644/papers?page=19